Oral vaccination, mucosal immunity and oral tolerance with special reference to cholera toxin

Concepts in Vaccine Development

Volumn , Issue , 2012, Pages 437-458

  Holmgren, Jan ^a   Czerkinsky, Cecil ^a   Sun, Jia Bin ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85064862604     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Auchincloss, Jr., H. and Sachs, D. H. (1993) Transplantation and graft rejection. In: Paul, W. E. (ed.), Fundmental Immunology, 3 ed., Raven Press, New York, 1099-1142
2. Black, R. E., Levine, M. M., Clements, M. L., Young, C. R., Svennerholm, A.-M., and Holmgren, J. (1987) Protective efficacy in man of killed whole vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect. Immun. 55, 1116-1129
3. Brandtzaeg, P. (1995) Basic mechanisms of mucosal immunity-A major adaptive defense system. The Immunologist 3, 89-96
4. Challacombe, S. J. and Tornasi, T. B. Jr. (1980) Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152, 1459-1472
5. Chase, M. W. (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. 61, 257-259
6. Chiller, J. M., Habicht, G. S., and Weigle, W. O. (1991) Kinetic differences in unresponsivenss of thymus and bone narrow cells. Science 171, 813-815
7. Clemens, J., Sack, D. A., Harris, J. R., Chakraborty, J., Khan, M. R., Stanton, B. F., Kay, B. A., Khan, M. U., Yunus, M. D., Svennerholm, A.-M., and Holmgren, J. (1986) Field trial of oral cholera vaccines in Bangladesh. Lancet i, 124-127
8. Clemens, J., Sack, D., Harris, J. R., Chakraborty, J., Neogy, P. K., Stanton, B., Huda, N., Khan, M. U., Kay, M. R., Khan, M. R., Ansaruzzaman, M., Yunus, M., Rao, M. R., Svennerholm, A.-M., and Holmgren, J. (1988a) Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: Results of a large-scale field trial. J. Infect. Dis. 158, 372-377
9. Clemens, J. D., Sack, D. A., Harris, J. R., Chakraborty, J., Khan, M. R., Stanton, B. F., Ali, M., Ahmed, F., Yunus, M., Kay, B. A., Khan, M. U., Rao, M. R., Svennerholm, A.-M., and Holmgren, J. (1988b) Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. Lancet i, 1375-1379
10. Clemens, J. D., Sack, D. A., Harris, J. R., Van Loon, F., Chakraborty, J., Ahmed, F., Rao, M. R., Khan, M. R., Yunus, M. D., Huda, N., Stanton, B. F., Kay, M. R., Walter, S., Eeckels, R., Svennerholm, A.-M., and Holmgren, J. (1990) Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet i, 270-273
11. Czerkinsky, C. and Holmgren, J. (1995) The mucosal immune system and prospects for antiinfectious and anti-inflammatory vaccines. The Immunologist 3, 97-103
12. Czerkinsky, C., Russell, M. W., Lycke, N., Lindblad, M., and Holmgren, J. (1989) Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues, Infect. Immun. 57, 1072-1077
13. de Aizpurua, H. J. and Russell-Jones, G. J. (1988) Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 167, 440-451
14. Dertzbaugh, M. T. and Elson, C. O. (1991) Cholera toxin as a mucosal adjuvant. In: Spriggs, D. R. and Koff, W. C. (eds.), Topics in Vaccine Adjuvant Research, CRC Press, Boca Raton, 119-132
15. Drew, M. D., Estrada-Correa, A., Underdown, B. J., and McDermott, M. R. (1992) Vaccination by cholera toxin conjugated to a herpes simplex virus type 2 glycoprotein D peptide. J. Gen. Virol. 73, 2357-2366
16. Elson, C. O. and Ealding, W. (1984a) Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132, 27-36
17. Elson, C. O. and Ealding, W. (1984b) Cholera toxin did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated antigen. J. Immunol. 133, 2892
18. Evans, D. J. Jr. and Evans, D. G. (1989) Determinants of microbial attachment and their genetic control. In: Farthing, M. J. G. and Keusch, G. T. (eds.), Enteric infection. Mechanisms, manifestations and management. Chapman and Hall, London, 15
19. Farthing, M. J. G. and Keusch, G. T. (eds.) (1989) Enteric infection. Mechanisms, manifestations and management. Chapman and Hall, London
20. Gallin, J. I. (1993) Inflammation. In: Paul, W. E. (ed.), Fundmental Immunology, 3 ed., Raven Press, New York, 1015-1032
21. Hansson, D. G., Vaz, N. M., Rawlings, L. A., and Lynch, J. M. (1979) Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization. J. Immunol. 122, 2261-2266
22. Hirabayashi, Y., Tamamura, S.-I., Suzuki, Y., Nagamine, T., Aizawa, C., Shimada, K., and Kurata, T. (1991) H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody responses to influenza virus haemagglutinin. Immunology 72, 329-335
23. Holme, T., Holmgren, J., Merson, M. H. et al. (eds.) (1981) Acute enteric infections in children: New prospects for treatment and prevention. Elsevier/North-Holland, Amsterdam
24. Holmgren, J. (1981) Actions of cholera toxin and the prevention and treatment of cholera. Nature 292, 413-417
25. Holmgren, J. and Svennerholm, A.-M. (1983) Cholera and the immune response. Progr. Allergy 33, 106-119
26. Holmgren, J. and Lindholm, L. (1976) Cholera toxin, ganglioside receptors and the immune response. Immunol. Commun. 5, 737-756
27. Holmgren, J., Svennerholm, A.-M., Lönnroth, I., Fall-Persson, M., Markman, B., and Lundbäck, H. (1977) Development of improved cholera vaccine based on subunit toxoid. Nature (Lond) 269, 602-604
28. Holmgren, J., Svennerholm, A.-M., Jertborn, M., Clemens, J., Sack, D. A., Salenstedt, R., and Wigzell, H. (1992) An oral B subunit: whole cell vaccine against cholera. Vaccine 10, 911-914
29. Holmgren, J., Lycke, N., and Czerkinsky, C. (1993) Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11,1179-1184
30. Holmgren, J., Czerkinsky, C., Lycke, N., and Svennerholm, A.-M. (1994) Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier and adjuvant. Am. J. Trop. Med. 50, 42-54
31. Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S., and Elson, C. O. (1994) Oral tolerance in humans. T cell but not T cell tolerance after antigen feeding. J. Immunol. 152,4663-4670
32. Jertborn, M., Svennerholm, A.-M., and Holmgren, J. (1988) Five-year immunological memory in Swedish volunteers after oral cholera vaccination. J. Infect. Dis. 157, 374-377
33. Jertborn, M., âhrén, C., Holmgren, J., and Svennerholm, A.-M. (1996) Clinical trials of an oral inactivated enterotoxigenic Escherichia coli vaccine. In press
34. Lange, S., Nygren, H., Svennerholm, A.-M., and Holmgren, J. (1980) Antitoxic cholera immunity in mice: Influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of intestine. Infect. Immun. 28, 17-23
35. Lehner, T., Bergmeyer, L. A., Panagiotidi, C., Tao, L., Brookes, R., Klavinskis, L. S., Walker, P., Walker, J., Ward, R. G. et al. (1992) Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258, 1365-1369
36. Liang, X., Lamm, M. E., and Nedrud, J. G. (1988) Oral administration of cholera toxin Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 141, 3781-3787
37. Lycke, N. and Holmgren, J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301-308
38. McDermott, M. R. and Bienenstock, J. (1979) Evidence for a common mucosal immunologic system: I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122, 1892-1898
39. McDermott, R. P. and Elson, C. O. (eds.) (1991) Mucosal Immunology I: Basic Principles. Gastroenterology Clinics of North America, WB Saunders, Philadelphia 1991 Mucosal Immunology II: Clinical Applications
40. McDermott, R. P. and Elson, C. O. (eds.) (1992) Mucosal Immunology II: Clinical Applications. Gastroenterology Clinics of North America, WB Saunders, Philadelphia 1992
41. McKenzie, S. J. and Halsey, J. F. (1984) Cholera toxin B subunit as a carrier protein to simulate a mucosal immune response. J. Immunol. 133, 1818-1824
42. Mestecky, J. (1987) The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7, 265-276
43. Mestecky, J. and McGhee, J. R. (1989) Oral immunization: past and present. Curr. Top. Microbiol. Immunol. 146, 1-11
44. Michalek, S. M., Eldridge, J. H., Curtiss III, R., and Rosenthal, K. L. (1994) Antigen delivery systems: new approaches to mucosal immunization. Handbook of Mucosal Immunology, Academic Press, 373-390
45. Mowat, A. M. (1987) The regulation of immune response to dietary protein antigens. Immunol. Today 8, 93-98
46. Nedrud, J. G., Liang, X., Hague, N., and Lamm, M. E. (1987) Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139, 3484-3492
47. Ogra, P. L., Chiba, Y., Beutner, K. R., and Morag, A. (1976) Vaccination by non-parenteral routes: characterization of immune response. Dev. Biol. Stand. 33, 19-26
48. Peltola, H., Siitonen, A., Kyrönseppä, H., Simula, I., Mattila, L., Oksanen, P. et al. (1991) Prevention of travellers' diarrhoea by oral B-subunit/whole cell cholera vaccine. Lancet 338, 1285-1289
49. Pierce, N. S. and Gowans, J. L. (1975) Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J. Exp. Med. 142, 1550-1563
50. Quiding, M., Nordstrom, I., Kilander, A., Andersson, G., Hanson, L. â., Holmgren, J., and Czerkinsky, C. (1991) Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses, gamma-interferon production, and evokes local immunological memory. J. Clin. Invest. 88, 143-148
51. Rebien, W., Puttonen, E., Maasch, H. J., Stix, E., and Wahn, U. (1982) Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study. Eur. J. Pediatry 138, 341-344
52. Sanchez, J. and Holmgren, J. (1989) Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc. Natl. Acad. Sci. USA 86, 481-485
53. Sanchez, J., Johansson, S., Löwenadler, B., Svennerholm, A.-M., and Holmgren, J. (1990) Recombinant cholera toxin B-subunit and gene fusion proteins for oral vaccination. Res. Microbiol. 141,911-919
54. Sanchez, J. L., Vasques, B., Begue, R. R., Meza, R., Castellares, G., Cabezas, C., Watts, D. M., Svennerholm, A.-M., Sadoff, J. C., and Taylor, D. N. (1994) Protective efficacy of the oral, whole cell/recombinant B subunit cholera vaccine in Peruvian military recruits. Lancet 344, 1273-1276
55. Schwartz, R. H. (1993) Immunological tolerance. In: Paul, W. E. (ed.) Fundamental Immunology, 3 ed., Raven Press, New York, 677-732
56. Schwartz, R. S. (1993) Autoimmunity and autoimmune diseases. In: Paul, W. E. (ed.) Fundmental Immunology, 3 ed., Raven Press, New York, 1033-1098
57. S toll, B. J., Svennerholm, A.-M., Gothefors, L., Barua, D., Huda, S., and Holmgren, J. (1986) Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in endemic areas. J. Infect. Dis. 755, 527-534
58. Sun, J. B., Holmgren, J., and Czerkinsky, C. (1994) Cholera toxin B subunit: An efficient transmucosal delivery system for induction of peripheral tolerance. Proc. Natl. Acad. Sci. USA 91, 10795-10799
59. Sun, J. B., Rask, C., Olsson, T., Holmgren, J., and Czerkinsky, C. (1996) Prevention and reversal of experimental autoimmune encephalomyelitis by oral tolerization with myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA, in press
60. Svennerholm, A.-M., Sack, D. A., Holmgren. J., and Bardhan, P. K. (1982) Intestinal antibody responses after immunization with cholera B subunit. Lancet i, 305-308
61. Svennerholm, A.-M., Jertborn, M., Gothefors, L., Karim, A. M. M. M., Sack, D. A., and Holmgren, J. (1984a) Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149, 884-893
62. Svennerholm, A.-M., Gothefors, L., Sack, D. A., Bardhan, P. K., and Holmgren, J. (1984b) Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes. Bull WHO 62, 909-918
63. Svennerholm, A.-M., âhren, C., Wennerâs, C., and Holmgren, J. (1991) Development of an oral vaccine against enterotoxigenic Escherichia coli diarrhea. In: Molecular pathogenesis of gastrointestinal infections. Wadström, T. et al. (eds.) PLENUM, London, 287-294
64. Trentham, D. E., Dynesius-Trentham, R. A., Orav, E. J., Combitchi, D., Lorenzo, C., Sewett, K. L., Hafler, D. A., and Weiner, H. L. (1993) Effects of oral administration of collagen on rheumatorid arthritis. Science 261, 1727-1730
65. Walker, W. A., Wu, M., Isselbacher, K. J., and Block, K. J. (1975) Intestinal uptake of micromolecules. IV. The effect of pancreatic duct ligation on the break down of antigen-antibody complexes on the intestinal surface. Gastroenterology 69, 1223-1229
66. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E., and Hafler, D. A. (1993a) Oral tolerance: Immunological mechanisms and treatment of murine and human organ specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 12, 809-837
67. Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M., and Hafler, D. A. (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple schlerosis. Science 259, 1321-2324
68. Wells, H. (1911) Studies on the chemistry of anaphylaxis III. Experiments with isolated proteins, especially those of hen's egg. J. Infect. Dis. 9, 147-171
69. Whitacre, C. C., Gienapp, C., Orosz, I. E., and Bitar, D. (1991) Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147, 2155-2163
70. Wilson, A. D., Clarke, C. J., and Stokes, C. R. (1990) Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Immunol. 31, 433-451
71. World Health Organization (1994) Diarrhoeal and acute respiratory disease control. Interim report, Geneva
72. Wortmann, F. (1977) Oral hyposensitization of children with pollinosis or house dust asthma. Allergol et Immunopathol. 5, 15-26
73. âhrén, C, Gothefors, L, Stoll, B., and Salek, M. A. (1982) Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens. Infect. Immun. 38, 74-79
74. âhrén, C., Wennerâs, C., Holmgren, J., and Svennerholm, A.-M. (1993) Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine 11, 929-934